Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
We report a 7-year-old girl with extensive toxic epidermal necrolysis (TEN) and neutropenia who was successfully treated using recombinant granulocyte colony-stimulating factor. Our patient had extensive epidermal loss and neutropenia, both indicators of a poor prognosis, but none the less made a rapid and complete recovery.
Goulden
V
V
Dermatology Department, Leeds General Infirmary, U.K.
Goodfield
M J
MJ
D002648:Child; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000628:therapy; D013262:Stevens-Johnson Syndrome / Q000628:therapy*
D016179:Granulocyte Colony-Stimulating Factor